Quest Partners LLC Rhythm Pharmaceuticals, Inc. Transaction History
Quest Partners LLC
- $1.02 Trillion
- Q2 2025
A detailed history of Quest Partners LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 1,470 shares of RYTM stock, worth $130,197. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,470
Previous 6,607
77.75%
Holding current value
$130,197
Previous $350 Million
73.46%
% of portfolio
0.01%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding RYTM
# of Institutions
251Shares Held
63MCall Options Held
403KPut Options Held
62.8K-
Black Rock Inc. New York, NY6.74MShares$597 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$539 Million6.69% of portfolio
-
Primecap Management CO Pasadena, CA5.79MShares$513 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$496 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$305 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $4.94B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...